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Salivary glands are involved in secretion of saliva, which is known to participate in the protection and hydratation of mucosal structures within
the oral cavity, oropharynx and oesophagus, the initiation of digestion, some antimicrobial defence, and the protection from chemical and
mechanical stress. Saliva secretion is a watery fluid containing electrolytes and a mixture of proteins and can be stimulated by muscarinic and
adrenergic agonists. Since water movement is involved in saliva secretion, the expression, localization and function of aquaporins (AQPs) have
been studied in salivary glands. This review will focus on the expression, localization and functional roles of the AQPs identified in salivary
glands. The presence of AQP1, AQP5 and AQP8 has been generally accepted by many, while the presence of AQP3, AQP4, AQP6 and AQP7 still
remains controversial. Functionally, AQP5 seems to be the only AQP thus far to be clearly playing a major role in the salivary secretion process.
Modifications in AQPs expression and/or distribution have been reported in xerostomic conditions.
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three extracellular and two intracellular loops. The loops B and E, folding in the
lipid bilayer, form a single aqueous pore.1. Introduction
For several decades, the existence of proteins forming water-
specific channels was postulated based on membrane perme-
ability measurements performed in cells and epithelia. In 1992,
the first water-specific channel, formerly called CHIP28 and
now aquaporin-1 (AQP1), was cloned and biophysically
characterized [1,2]. Since then, other aquaporins (AQPs) have
been cloned from mammals and the AQP family has grown to
13 members (AQP0 to AQP12). The AQPs are small
hydrophobic integral membrane proteins of about 270 amino
acids expressed widely in the animals and plants. AQPs exist as
monomers of ±30 kDa [1] and their hydropathy analyses
showed the presence of six transmembrane helices in each
monomer, as well as three extracellular and two intracellular
loops ([3]; Fig. 1). The signature amino acid sequence motifs of
the AQPs, two repeating Asn–Pro–Ala (NPA) sequences, are
present in the first intracellular and the third extracellular loop
([4]; Fig. 1). According to the “hourglass model” and
crystallographic studies, these two loops connect in the centre
of the lipid bilayer and form a hydrophilic pore for the water
transfer through the lipid bilayer [5]. A single N-glycosylation
site, present in the second extracellular loop, accounts for the
detection of glycosylated and non-glycosylated forms of AQP1
by immunoblotting (Fig. 1). In the plasma membrane, AQP1
assembles in tetramers [6] and each monomer contains a water
channel [5]. For AQP1, the water selectivity is due to both the
size-exclusion effect of the channel [4,7], and the orientation of
Asn in the NPA motifs providing necessary hydrogen-bonding
interactions to separate water molecules and avoid proton flow
through the channel [4,8].
On the basis of their permeability characteristics that coincide
generally with their specific amino acid sequence motifs, the
members of the AQP family can be divided into two groups: the
aquaporins and the aquaglyceroporins. The aquaporins are
primarily permeable to water (AQP0, AQP1, AQP2, AQP4,
AQP5, AQP6, and AQP8) whereas the aquaglyceroporins
(AQP3, AQP7, AQP9 and AQP10) also transport glycerol and
small solutes (reviewed by [4,9,10]). The transport function of
many AQPs can be inhibited by mercurial–sulfhydral-reactive
compounds such as HgCl2 [11].
Mammals possess threemajor pairs of salivary glands: parotid,
submandibular and sublingual aswell as numerousminor salivary
glands scattered among the oral cavity. Salivary glands are
composed of acinar cells either serous or mucous, and ductal cells
of several varieties. Saliva is a watery fluid containing electrolytes
and a mixture of proteins. The Na+/K+ ATPase, located at the
basolateral membrane of acinar cells, produces an inward-directed Na+ chemical gradient (Fig. 2). The Na+/K+/2Cl−
cotransporter, located at the basolateral membrane, uses the Na+
gradient to elevate the intracellular Cl− concentration. Intracel-
lular Cl− level also increases through the paired basolateral Cl−/
HCO3
− and Na+/H+ exchangers. The Na+-dependent Cl− uptake
mechanism allows concentration of intracellular Cl− above its
electrochemical gradient. Agonist-stimulated saliva secretion is
initiated by the opening of K+ and Cl− channels located in the
basolateral and apical membranes, respectively. HCO3
− is secreted
across the apical membrane via an ion channel, possibly via the
same channel involved in Cl− secretion. The opening of K+ and
Cl− channels leads to a negative electrical potential difference
allowing the passive movement of cations across the acinar cell
tight junctions. The accumulation of ions in the lumen generates a
transepithelial osmotic gradient driving water movement through
the apical AQP5 channels and paracellular pathways. This leads
to the secretion of an isotonic plasma-like primary fluid ([12]; Fig.
2). Although little is known about ion transport pathways in
salivary ducts, while saliva passes through the ducts, NaCl is
resorbed via Na+ channels, Cl− channels, and Na+/H+ exchan-
gers, while K+ and HCO3
− are excreted via Cl−/HCO3
− and K+/H+
exchangers (Fig. 2). The resulting hypotonic secreted saliva is due
to the relative impermeability of the ducts to water [13–17]. The
final saliva composition depends on both the origin of the
stimulation (sympathetic or parasympathetic) and the type of
salivary gland stimulated.
Typically, humans secrete about 1 l of saliva per day. The
functions of saliva include the protection and hydration of
mucosal structures within the oral cavity, oropharynx and
oesophagus, the initiation of digestion, some antimicrobial
defence, and the protection from chemical and mechanical stress.
Table 1
AQPs localization in salivary gland cell types
AQP Cell type Subcellular localization Remarks
Rat Human
AQP1 Endothelial A+B [19–24] [25,26,28,33]
Myoepithelial
AQP3 Acinar B [26,33] Controversial
data: see
[20,23,24]
AQP4 Ductal B [46] Controversial
data: see
[23,24,26,27,47]
AQP5 Acinar A [21,47,50,61] [26,55,79]
B [51] Not confirmed
by others
SG [51] Not confirmed
by others
Ductal A [47,52,54] Controversial
data: see
[21,50,53]
AQP6 Unknown Controversial
data
AQP7 Unknown Controversial
data
AQP8 Myoepithelial [88,89]
References are indicated between brackets. A: apical; B: basolateral; SG:
secretory granules.
Fig. 2. Salivary secretion. The acinar cell secretes a primary isotonic plasma-like fluid based on the entry of Cl− across the basolateral membrane and its exit across the
apical membrane. During the passage of saliva through the ducts, NaCl is resorbed while K+ and HCO3
− secreted. All the known ion transporters involved in these
processes are indicated in the figure.
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pain, increased dental carries, and infections by opportunistic
microorganisms [18].
The expression, localization and functional roles of the AQPs
detected in salivary glands (AQP1, AQP3, AQP4, AQP5, AQP6,
AQP7 andAQP8; see Table 1) are discussed in the present review.
2. AQP1
2.1. Normal salivary glands
In rat parotid glands, both AQP1 mRNA and protein were
detected [19]. Immunolocalization studies using thin and
ultrathin cryosections and light and electron microscopy
revealed no labelling of the glandular tissue. In contrast,
labelling was detected on both apical and basolateral mem-
branes from non-fenestrated endothelial cells of capillaries and
venules [19–22]. In rat submandibular gland, AQP1 expression
was shown to be constitutive and distributed to microvascula-
ture during embryonic and postnatal development [23,24].
In human salivary glands including parotid, submandibular,
sublingual and labial, AQP1 mRNA was detected by RT-PCR
[25–27]. AQP1 immunoreactivity was not confined to the
capillaries, but also associated with myoepithelial cells. These
are contractile cells with polygonal cell body, central nucleus, and
long tapering processes that form a basketlike framework around
the acini and smaller ducts [25,26]. Normal tissue microarray
using parotid salivary gland revealed some AQP1 expression.
Additional immunohistochemistry and semiquantitative histo-
morphometric analyses indicated that AQP1 expression was
localized to endothelial barriers and myoepithelial cells [28].
In transgenic mice lacking AQP1, pilocarpine-induced of
salivary secretion showed no defect in volume or composition
of saliva [37,38]. These data suggested that AQP1 does not play
a major role in saliva secretion.
2.2. Salivary glands from Sjögren’s syndrome patients
Sjögren's syndrome is a common inflammatory disease
characterized by lymphocytic infiltration of salivary andlacrimal glands leading to glandular hypofunction and dry
mouth and eyes [29]. Several factors may contribute to impaired
salivary flow, including proinflammatory cytokines, such as
interleukin-1 and tumour necrosis factor-α (TNF-α), that can
inhibit both basal and stimulated secretion [30,31]. In Sjögren's
syndrome patients, the presence of autoantibodies against M3R
could prevent the normal salivary secretion in response to
neuronal stimulation [32]. In biopsies of labial salivary gland
from Sjögren's syndrome patients, compared to control
subjects, the AQP1 distribution was decreased by 38% in
myoepithelial cells. No change was observed in endothelial
cells of nonfenestrated capillaries [33].
Decreased AQP1 expression in myoepithelial cells from the
labial salivary glands of Sjögren's syndrome patients has led to
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its pathogenesis [33]. Myoepithelial cell contraction [39] can be
induced by the type 3 muscarinic receptor (M3R) activation in
response to acetylcholine [40]. Also, cell volume variation
mediated by AQP1 might contribute to vascular smooth muscle
contraction [41]. If AQP1, similarly to AQP5 [42], translocates
upon M3R stimulation, AQP1 might contribute to rapid
myoepithelial cell volume modifications and contraction [41].
Since myoepithelial cells embrace the acini, their contraction
would constrict the lumen of the acini and facilitate saliva flow.
Nevertheless, this hypothesis is not supported by the data
obtained with transgenic mice lacking AQP1 [37,38].
2.3. Salivary gland cell lines
Well-studied salivary epithelial cell lines have been shown to
be useful tools to study the cell biology of salivary glands. The
HSG cell line derived from an irradiated human submandibular
gland and thought to originate from pluripotential intercalated
duct region [34] did not express AQP1 [35]. The SMIE cell line,
derived from rat submandibular epithelial duct cells immortal-
ized with adenovirus 12S E1A gene product is also devoid of
AQP1 expression [36]. However, the A5 cell line, derived from
rat submandibular epithelial cells transformed with 3-methyl-
cholanthrene and sharing immunological characteristics with
intra- and extra-lobular salivary ducts cells [36], was shown to
express both AQP1 mRNA and protein as well as a high water-
permeability coefficient inhibited by HgCl2 [35]. The presence
of AQP1 in A5 cells, exhibiting ductal immunological
characteristics, seems rather inappropriate considering the
water impermeability of intra- and extra-lobular ducts [13–17].
Following mitogenic stimulation of quiescent 3T3 mouse
fibroblastic cells, DER-2 (the murine homolog of AQP1) was
among the early-delayed response genes activated in response
to 20% foetal bovine serum [43]. This observation suggested
that AQP1 could be involved in cellular growth control. In A5
cells, the presence of AQP1 [35] might reflect the loss of growth
control associated with transformation. AQP1 expression was
first shown to vary during the cell cycle in A5 cells. The highest
protein levels were observed when most cells were in G0/G1
followed by a 40–60% decrease when cells moved into S and
G2/M phase [44]. Since changes in cell size occur during cell
division, AQP1 level modification, and consequently water-
permeability fluctuation, might be necessary during that
process.
3. AQP3 and AQP4
3.1. Normal salivary glands
During prenatal, but not postnatal, development of rat
submandibular gland, AQP3 mRNA was detected by RT-PCR
but not by Northern blot analysis or in situ hybridization [24].
Western blot analysis [23] as well as immunohistochemical
analysis [20] did not reveal the AQP3 protein in rat
submandibular gland. Thus, the expression of AQP3 in rat
salivary glands is not clear at present.In human parotid, submandibular, sublingual and labial
salivary glands, AQP3 mRNA was detected by RT-PCR and
Northern blot analysis [26,27]. Moreover, immunoreactive
AQP3 was localized at basal and lateral, but not apical,
membranes of both serous and mucous acinar cells, but not in
ductal cells [26,33]. However, these observations have not been
confirmed by other studies.
Contradictory data also exist for the assessment of AQP4
expression in rat salivary glands. Indeed, AQP4 mRNA was
detected [45] or not [24] by RT-PCR in adult rat submandibular
gland. During prenatal development of rat submandibular
gland, AQP4 mRNA was detected by RT-PCR but not by
Northern blot analysis [24]. Although AQP4 protein was
localized by immunohistochemistry to epithelial cells of
excretory ducts in rat submandibular gland, primarily at the
basolateral membrane [46], both Western blot analysis of gland
membranes [23] and other immunohistochemical studies [47]
were unable to detect the AQP4 protein in rat submandibular
gland.
In human parotid, submandibular, sublingual and labial
salivary glands, AQP4 mRNAwas detected by RT-PCR but not
by Northern blot analysis [26,27]. Moreover, AQP4 protein was
not detected by immunohistochemistry on salivary gland
sections [26].
In both rat and human salivary glands, the AQP4 expression
still remains controversial. If present, AQP4 might be expressed
either at low levels or only in a small fraction of the cell
population of the salivary gland.
No data are currently available concerning possible func-
tional role of AQP3 in the salivary secretion process. In
transgenic mice lacking AQP4 pilocarpine-stimulation of
salivary secretion showed no defect in volume or composition
of saliva [37,38]. These data suggested that AQP4 does not play
a major role in saliva secretion.
3.2. Salivary glands from Sjögren’s syndrome patients
Compared to control subjects, in Sjögren's syndrome
patients labial salivary gland biopsies, the AQP3 distribution
(basolateral membrane) was not altered in acinar cells [33].
Those data suggested that AQP3 was not involved in the
pathogenesis of Sjögren's syndrome.
Since AQP3 distribution was not modified in acinar cells
from labial salivary gland biopsies from Sjögren's syndrome
patients, compared to control subjects [33], it is unlikely that
AQP3 might be involved in the pathogenesis of Sjögren's
syndrome.
4. AQP5
4.1. Expression and localization
4.1.1. Normal salivary glands
AQP5, initially isolated from rat submandibular gland [48],
was also detected in rat [23,48] and mouse [49] parotid,
submandibular and sublingual glands. Strong AQP5 labelling
was located in the apical membrane, including the
1065C. Delporte, S. Steinfeld / Biochimica et Biophysica Acta 1758 (2006) 1061–1070intercellular canaliculi, of serous-type acinar cells from rat
submandibular [21,47,50] and from rat minor salivary glands
[51]. A weak AQP5 labelling located at the apical membrane
of mucous-type acinar cells was observed in rat minor
salivary gland [51], but not in rat submandibular gland [50].
Very weak AQP5 labelling was observed in basal and lateral
membranes of acinar cells in rat minor salivary gland [51],
but not in rat submandibular gland [50]. At high magnifica-
tion, confocal microscopy revealed that the apical acinar
AQP5 labelling observed in rat minor salivary gland did not
form a straight line, but rather dispersed omega-shape
indentations, suggesting AQP5 might be present in secretory
granules [51].
The Sprague–Dawley rat strain could be divided in two
groups regarding the high or low level of AQP5 expression in
rat submandibular gland. In animals expressing high level of
AQP5, the AQP5 protein was localized at the apical, basal and
lateral membrane of acinar cells as previously described [52],
while in animals expressing low level of AQP5, the AQP5
protein was confined to the apical and/or lateral membrane of
acinar cells [53].
In duct cells from rat submandibular glands, while most
studies could not detect any AQP5 staining [21,50,53], few
studies observed some apical staining in intercalated duct cells
[47,52]. In rat parotid and sublingual salivary gland, no AQP5
staining was detected in the duct system [52]. In rat parotid
tissue slices, some intracellular AQP5 labelling was detected in
interlobular duct cells [54], but these findings still remain to be
confirmed by others.
In human parotid, AQP5 mRNA was detected by RT-PCR
[27]. In human parotid, submandibular, sublingual and labial
glands, AQP5 labelling was confined to the apical membrane of
acinar cells and not detected in duct cells [26,55].
4.1.2. Salivary gland cell lines
In A5 and SMIE rat submandibular salivary gland cell lines
from ductal origin, the AQP5 expression was lacking [44].
An immortalized normal human salivary ductal (NS–SV–
DC) cell line, lacking the expression of AQP5, acquires AQP5
gene expression in response to treatment with 5-aza-2′-
deoxycitidine (5-Aza-CdR), a DNA demethylation agent [56].
The expressed AQP5 protein was mainly localized at the apical
and lateral membrane of the cells, and was functionally active
[56]. 5-Aza-CdR induces demethylation of two GC sites
cooperatively in the AQP5 promoter to provoke AQP5 gene
expression [56]. Since ductal cells are the main component of
salivary glands following radiation therapy or Sjögren's
syndrome, 5-Aza-CdR was suggested to provide efficient and
useful means to impart facilitated water permeability to
remaining ductal cells [56]. It should however be taken into
account that agents inducing DNA demethylation are potential
carcinogens.
4.2. Intracellular trafficking of AQP5
The translocation of AQP5 between intracellular and apical
membranes from rat parotid gland (acini and ducts) occurs afterM3R [42] or α1-adrenergic receptor [57,58] stimulation. This is
thought to be due to an elevation in intracellular calcium
concentration involving the stimulation of the nitric oxide/
cyclic GMP pathway [59]. In rat minor salivary gland acinar
cells, upon isoproterenol stimulation, the AQP5 labelling
initially present in secretory granules became dispersed,
suggesting that part of the apical membrane containing AQP5
are retrieved following exocytosis [51].
While only transient translocation of AQP5 to the apical
membrane occurs following acetylcholine stimulation, long-
lasting translocation of AQP5 could be obtained following
SNI-2011 stimulation [60]. Since AQP5 trafficking studies
were performed on tissue sections using biochemical methods,
it was not clear if AQP5 could be subject to regulated
trafficking in vivo. That issue was addressed by looking at
AQP5 localization in rat parotid and submandibular gland after
short in vivo stimulation (using muscarinic or adrenergic
agonists) or inhibition (using muscarinic or adrenergic
antagonist) of saliva secretion [61]. Under control conditions,
most of the AQP5 labelling (> 90%) was associated with the
apical membrane of acinar cells in both parotid and
submandibular glands and intercalated duct cells in subman-
dibular gland. While only rare AQP5 labelling was associated
with intracellular membrane domains [61]. Short intervals (3 or
10 min) of stimulation or inhibition of salivary secretion did
not reveal any significant translocation of AQP5 between
intracellular vesicles or secretory granules and the apical
plasma membrane [61]. One can, however, not exclude that
shorter or longer stimulation or inhibition of salivary secretion
might lead to AQP5 trafficking, or that the anaesthetic used in
these experiments to tranquilize the animals may have
interfered with protein trafficking.
AQP5 trafficking was observed in intracellular structures of
interlobular duct cells following M3R agonist stimulation
[54,62]. Also, AQP5 translocated with lipid rafts from
intracellular structures to the apical membrane of interlobular
duct cells, and then AQP5 moved from the lipid rafts to non-
rafts within the apical membrane [54]. These data should be
considered with care since the presence of AQP5 in interlobular
duct cells still remains to be confirmed by others. Also, it should
be determined if the AQP5 translocation occurs in all duct
types, and if this mechanism is physiologically relevant
regarding salivary secretion since duct cells have been
considered water impermeable [13–17].
In rat parotid gland, AQP5 has been shown to be involved in
osmoregulation of the secretory granules [63]. In light of these
recent data [63] and the hypothesis that AQPs can function as
osmotic sensors, rather than water channels [64,65], AQP5 has
been suggested to act as an osmosensor in the secretory granules
from rat parotid gland. AQP5 was colocalized with the small
GTP-binding proteins Rab4 from the apical endosome of acinar
cells, suggesting that Rab4 participated in both endocytosis of
the apical membrane and the transport of apical membranes
components such as AQP5 [66].
In rat AQP5-transfected HSG cells, the AQP5 trafficking
from intracellular vesicles to plasma membrane was shown to
be triggered by intracellular calcium concentration increase and
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cytoskeleton [67]. Polarized differentiated HSG cells expres-
sing an acinar phenotype after culture on a basement membrane
matrix [68] could have been a more appropriate model to study
such protein trafficking.
4.3. Functional roles
Compared to wild-type mice, transgenic mice lacking AQP5
displayed reduced pilocarpine-stimulated saliva secretion
(∼60%), hypertonic (420 mosm) and more viscous saliva,
while amylase and protein secretion were not modified [37].
This suggested that AQP5 played a key role in saliva fluid
secretion and that high epithelial cell membrane water
permeability is required for active near-isosmolar fluid
transport. Further studies showed that hyposalivation was not
caused by changes in whole body fluid homeostasis, but instead
that water membrane permeability of salivary gland acinar cells
was dramatically reduced in mice lacking AQP5 [69].
The abundant presence of AQP5 in intercalated ducts from
rat submandibular gland suggests that AQP5 may play a role in
the absorption and/or secretion of small solutes. The fact that
AQP5 was not present in the duct system, with the exception of
the intercalated ducts from rat submandibular gland, is in
agreement with the water impermeability characteristics of the
duct cells [13–17]. Further studies are required to investigate
the functional role of AQP5 in the absorption and/or secretion of
small solutes in intercalated ducts.
In Sprague–Dawley rats, the variation of AQP5 expres-
sion observed in submandibular glands seems to account for
the variation of the saliva secretion rate observed between
high and low AQP5 expressors (7-fold higher saliva rate in
high expressors than low expressors) [53]. These data are in
agreement with the key role of AQP5 in saliva secretion
[37].
4.4. AQP5 and xerostomic conditions
Decreased salivary function (xerostomia) occurs for many
reasons associated with increased age, drug use, radiation
therapy of malignant tumours of the head and neck, and disease
(such as Sjögren's syndrome) [70].Fig. 3. AQP5 localization in human minor salivary gland. AQP5 was localized in m
Sjögren's syndrome (B) (×40), using affinity-purified anti-hAQP5 antibodies and a4.4.1. Senescence
In parotid glands (acini and ducts) from senescent rats,
decreased AQP5 translocation to the apical membrane in
response to acetylcholine, but not to epinephrine, was not due to
decreased M3R and/or Gq protein expression, but rather to
decreased nitric oxide synthase activity (NOS) [71]. NOS
activity has been shown to be involved in AQP5 translocation
[59]. In adult and senescent rats, the quinuclidine derivative
SNI-2011 (a structurally rigid analogue of acetylcholine called
cevimeline and known to act on M3R) was shown to induce
persistent increase in the amount of AQP5 in the apical
membrane of parotid gland, suggesting that this drug might be
therapeutically beneficial for the treatment of age-related
xerostomia [71].
4.4.2. Radiation therapy of malignant tumours of head and
neck
For most of the patients diagnosed each year with head and
neck cancer, ionizing radiation is a key component of therapy
but has the adverse effect to cause severe damage to the acinar
cells of the salivary glands lying in the radiation field [72]. In
irradiated salivary glands from patients with head and neck
cancer, the loss of AQP5 expression and possibly other proteins
involved in the secretory process may participate to the
mechanism that accounts for the loss of salivary flow observed
in irradiated rat salivary glands [22,73]. In rat irradiated salivary
gland, the AQP5 labelling intensity was markedly decreased
[74], the number of AQP5-labelled intercalated ducts was
decreased and the acinar cells were devoid of AQP5 labelling
[Delporte, Redman and Baum, unpublished data]. Recombinant
adenovirus encoding AQP1 has been shown to be of therapeutic
benefit for the improvement of salivary secretion in irradiated
rats, non-human primates and miniature pigs salivary glands
([22,75,76] and for review: [77]).
4.4.3. Sjögren’s syndrome
Using anti-human AQP5 antibodies, the immunohistochem-
ical distribution of AQP5 in minor salivary glands biopsies from
normal subjects, as well as from non-Sjögren's syndrome
patients with dry mouth, revealed AQP5 primarily at the apical
membranes of the acinar cells ([55]; Fig. 3). In contrast, in
minor salivary glands, biopsies from Sjögren's syndromeinor salivary gland sections from a control subject (A) (×40), or a patient with
Histostain SP kit (Zymed Lab. Inc., San Francisco, CA) [55].
1067C. Delporte, S. Steinfeld / Biochimica et Biophysica Acta 1758 (2006) 1061–1070patients, computer-assisted microscopy revealed that AQP5
labelling was higher at the basal membrane, and lower at the
apical membrane of acinar cells, compared with biopsies from
normal subjects ([55]; Fig. 3). In each case, Western blot
analysis revealed the presence of a 27-kDa band, corresponding
to the expected molecular weight of AQP5 [55]. From this
study, it was proposed that abnormal distribution of AQP5
could contribute to the deficiency of fluid secretion observed in
Sjögren's syndrome patients. The administration of anti-TNF-α
antibodies (infliximab) to Sjögren's syndrome patients dramat-
ically improved unstimulated salivary flow [55] and restored
proper apical localization of AQP5 in acinar cells from minor
salivary glands [78]. However, studies performed with anti-rat
AQP5 antibodies were not able to detect any AQP5 distribution
modification in labial salivary gland biopsies from Sjögren's
syndrome patients, compared to control subjects [79]. These
apparent contradictory data might be explained by the use of
anti-rat AQP5 antibodies that were shown to not cross-react
with the human AQP5 protein [78]. It is significant to note that
anti-human AQP5 antibodies altered AQP5 trafficking in
lacrimal gland biopsies from Sjögren's syndrome patients [80].
In salivary glands from non-obese diabetic mice, generally
considered as a good animal model for Sjögren's syndrome
[81,82], AQP5 distribution was not restricted to the apical
membrane of acinar cells as in control mice, but rather present at
both basolateral and apical membrane [83]. These data support
observations that implied a similar loss of the ordered and
polarized expression of AQP5 in human minor salivary glands
and lacrimal glands from patients with Sjögren's syndrome
[55,80].
4.4.4. Diabetes
In streptozocin-induced diabetic rats, SNI-2011 was unable
to induce the AQP5 translocation from lipid rafts to the apical
membrane in interlobular duct cells of parotid glands as of
control rats [62]. The defect in AQP5 trafficking could be
responsible for the xerostomia.
5. AQP6 and AQP7
Although AQP6 and AQP7 mRNAs were detected by RT-
PCR in human parotid gland [27], this has not been confirmed
by other studies. It is generally accepted that AQP6 is strictly
expressed in kidney [4,84]. AQP7 mRNA detection in human
parotid gland tissue [27] might be due to a sample contamina-
tion with adipocytes which are known to express AQP7 [85].
No data are currently available concerning possible functional
role of AQP6 or AQP7 in the salivary secretion process.
6. AQP8
6.1. Salivary glands
AQP8, originally cloned from rat pancreas and liver by
homology cloning, was detected by in situ hybridization in the
acinar cells from rat salivary glands [86]. By immunohisto-
chemistry, AQP8 originally was reported as detected in thebasolateral membrane of acinar cells from rat submandibular
glands [87]. However, Elkjaer et al. [88] reported a different
distribution: in myoepithelial cells around the acini and the
intercalated duct, but not in acinar or ductal cells, of rat parotid,
submandibular and sublingual cells. Wellner et al. [89] recently
have provided new data that indicate their agreement with the
conclusions of Elkjaer et al. [88].
Microarray analysis of gene expression during aging in rat
submandibular gland revealed a decrease in AQP8 (2.3-fold)
gene expression [90]. Further studies will be required to analyze
the consequence of decreased AQP8 gene expression in
senescent rats.
Transgenic mice lacking AQP8 compared to wild-type mice,
as well as AQP5/AQP8 double knockout mice compared to
AQP5-null mice, did not display any modified agonist-driven
saliva secretion [93]. Therefore, AQP8 does not appear to play a
major role in salivary secretion in mice.
6.2. Salivary gland cell lines
In the rat salivary epithelial SMIE cell line, AQP8 mRNA as
well as AQP8 protein were detected by RT-PCR and confocal
microscopy [91]. SMIE cells cultured on collagen-coated
polycarbonate filters can form a monolayer and exhibit
polarized morphology, authentic tight junctions and a polarized
membrane protein distribution [92]. On polarized SMIE cells,
AQP8 was detected at the apical membrane and its expression
was responsible for the fluid movement measured in response to
modified osmotic gradient [91].
7. Conclusions
In salivary glands, AQP1 was localized to endothelial and
myoepithelial cells (Table 1), and AQP8 in myoepithelial cells.
The data concerning the presence of AQP3, AQP4, AQP6 and
AQP7 are still controversial (Table 1). These AQPs do not
appear to play any important role in the salivary secretion
process. AQP5 was identified in acinar and intercalated duct
cells. Functionally, AQP5 seems to be the only salivary AQP
clearly playing a major role in the salivary secretion process.
Indeed, in normal physiological conditions, due to its presence
in acinar cells, AQP5 participates in water movement to the
lumen (Introduction, [37,53,69]). Agonist-stimulated saliva
secretion probably requires AQP5 trafficking from intracellular
vesicles or secretory granules to the apical plasma membrane of
acinar cells. However, some discrepancies exist between in vitro
experiments performed on salivary gland sections using
biochemical methods [51,57–60] and in vivo experiments
using immunohistological methods [61]. Several reasons could
account for those discrepancies: AQP5 trafficking in acinar and
ductal cells cannot be distinguished using tissues slices and
biochemical methods; the duration of the gland stimulation and
the anaesthetic chosen to study AQP5 trafficking in vivo may
not be optimal. Further studies need to be performed to clarify
whether AQP5 trafficking occurs in physiological conditions.
For example, analysis of AQP5 trafficking by confocal
microscopy following agonist addition to acinar or ductal cell
1068 C. Delporte, S. Steinfeld / Biochimica et Biophysica Acta 1758 (2006) 1061–1070preparations, as well as additional determination of AQP5
localization following distinct kinetics of stimulation and using
other anaesthetics, could be valuable to address the issue. The
fact that trafficking might be an important modulator of AQP5
localization, and therefore of AQP5 physiological function in
vivo, seems to be confirmed by the presence of a defect in
AQP5 translocation under various xerostomic conditions such
as senescence [59,71], Sjögren's syndrome [55,69,78,80,83],
and diabetes [62].
In ductal cells, shown as water impermeable [13–17],
AQP5 is unlikely to be physiologically relevant to the saliva
secretion mechanism. Therefore, further studies need to be
done to investigate the functional role of AQP5 trafficking
in ducts.
The secretion of a plasma-like primary fluid by the acinar
cells to the lumen requires the presence of AQP5 at the apical
membrane, and, evidently, of another water channel that
remains to be identified at the basolateral membrane. Further
studies will be necessary to identify the AQP present at the
basolateral membrane of acinar cells and determine its
functional role in the saliva secretion process.
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